Diagnostics subsidiary Aster Clinical Lab LLP has set up its pathology reference laboratory at Bengaluru.
Shares of Aster DM Healthcare rallied 10 percent intraday on May 7 as its subsidiary started providing RT-PCR confirmatory test service for COVID-19 in Bengaluru.
Diagnostics subsidiary Aster Clinical Lab LLP has set up its pathology reference laboratory at Bengaluru.
The laboratory is fully equipped with advanced instruments to serve routine & specialized investigation e.g. biochemistry, haematology, microbiology, molecular diagnostics, cytogenetics, digital histopathology etc, company said in its BSE filing.
"It has a state of the art molecular diagnostics department with accreditation from NABL and approval from ICMR, to start full-fledged testing of COVID-19 RT-PCR confirmatory test," it added.
The stock gained nearly 20 percent in last one-and-half-month period. It was quoting at Rs 97.75, up 2.89 percent on the BSE at 1509 hours IST.
Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
First Anniversary Offer: Subscribe to Moneycontrol PRO’s annual plan for ₹1/- per day for the first year and claim exclusive benefits worth ₹20,000. Coupon code: PRO365
First Published on May 7, 2020 03:32 pm
